에 대한 최신 뉴스 Marsh & McLennan (NYSE:MMC) 주식

Marsh & McLennan

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

Earnings

Equities

News

Markets

Movers

General

버크셔 해서웨이(NYSE:BRK)의 보험 운영 부회장인 아지트 자인(Ajit Jain)은 사이버 보험이 요즘 매우 세련된 공간이 되었다고 말했다. 지난 몇 년 동안 사이버 보험은 전 세계적으로 최소 100억 달러 규모의 시장이 되었다.지난 토요일 네브래스카주 오마하에서 열린 버크셔 해서웨이의 연례 주주총회에서 자인은 사이버 보험의 수익성도 전체 보험료(프리미엄)의 약 20%로 상당히 높다고 말했다.

버크셔 해서웨이의 아지트 자인은 위험 속에서 사이버 보험에 대해 주의 경고

Pre-Market Outlook

Trading Ideas

NFLX

CNN 머니(Money)의 ‘공포와 탐욕&#39; 지수는 전반적인 시장 심리가 더욱 악화하고 있는 가운데 수요일에도 여전히 ‘공포&#39; 구간에 머물렀다. 미국의 주식은 수요일 미국 S&amp;P 500 지수가 네 번째 하락하여 낙폭이 커졌다.

투자자 심리 부진, S&amp;P 500은 4일 연속 하락

미국 주식 선물이 목요일 오전 상승한 가운데, 투자자들의 관심을 끌 수 있는 몇 가지 주식은 다음과 같다: Benzinga Pro의 데이터에 의하면, 월가는 D.R. 호튼(NYSE:DHI)의 시장 개장 전 주당 3.06달러의 분기 실적과 82.7억 달러의 매출을 예상하고 있다. D.R. 호튼은 시간 외 거래에서 0.5% 하락한 145.00달러에 거래되었다.

목요일 주목해야 할 주식: D.R. 호튼, 넷플릭스 및 주식 3종목

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Companies Inc

NYLI MacKay California Muni Intermediate ETF

Members Co Ltd

MAG MILE CAPITAL,INC by Mag Mile Capital Inc.

Mag Mile Capital Inc

Andean Silver Ltd

Mind Medicine Inc Warrants(11/12/2023)

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TIGR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$17.00</td>
<td>$27.5K</td>
<td>0</td>
<td>7.5K</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$150.00</td>
<td>$156.0K</td>
<td>1.3K</td>
<td>5.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$22.00</td>
<td>$26.0K</td>
<td>1.9K</td>
<td>1.7K</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$140.00</td>
<td>$270.0K</td>
<td>1.2K</td>
<td>1.5K</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$40.00</td>
<td>$47.2K</td>
<td>5.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>HIG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$120.00</td>
<td>$28.7K</td>
<td>1.0K</td>
<td>391</td>
</tr>
<tr>
<td>MMC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$195.00</td>
<td>$242.1K</td>
<td>87</td>
<td>130</td>
</tr>
<tr>
<td>RKT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.00</td>
<td>$36.4K</td>
<td>251</td>
<td>50</td>
</tr>
<tr>
<td>NU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.00</td>
<td>$26.5K</td>
<td>4.2K</td>
<td>49</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/04/24</td>
<td>$482.50</td>
<td>$26.6K</td>
<td>10</td>
<td>22</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TIGR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>), we observe a call option sweep with bullish sentiment. It expires in 15 day(s) on October 18, 2024. Parties traded 1100 contract(s) at a $17.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $27.5K, with a price of $25.0 per contract. There were 0 open contracts at this strike prior to today, and today 7509 contract(s) were bought and sold. 
• Regarding FUTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), we observe a call option sweep with bullish sentiment. It expires in 15 day(s) on October 18, 2024. Parties traded 306 contract(s) at a $150.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $156.0K, with a price of $510.0 per contract. There were 1339 open contracts at this strike prior to today, and today 5207 contract(s) were bought and sold. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option sweep that happens to be bullish, expiring in 1 day(s) on October 4, 2024. This event was a transfer of 466 contract(s) at a $22.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $56.0 per contract. There were 1942 open contracts at this strike prior to today, and today 1708 contract(s) were bought and sold. 
• For BX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on November 15, 2024. This event was a transfer of 900 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $270.0K, with a price of $300.0 per contract. There were 1222 open contracts at this strike prior to today, and today 1500 contract(s) were bought and sold. 
• For BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on November 15, 2024. This event was a transfer of 236 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $47.2K, with a price of $200.0 per contract. There were 5276 open contracts at this strike prior to today, and today 1123 contract(s) were bought and sold. 
• For HIG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>), we notice a call option sweep that happens to be neutral, expiring in 15 day(s) on October 18, 2024. This event was a transfer of 379 contract(s) at a $120.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $28.7K, with a price of $77.0 per contract. There were 1094 open contracts at this strike prior to today, and today 391 contract(s) were bought and sold. 
• For MMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), we notice a call option trade that happens to be bullish, expiring in 15 day(s) on October 18, 2024. This event was a transfer of 90 contract(s) at a $195.00 strike. The total cost received by the writing party (or parties) was $242.1K, with a price of $2690.0 per contract. There were 87 open contracts at this strike prior to today, and today 130 contract(s) were bought and sold. 
• Regarding RKT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), we observe a call option sweep with bullish sentiment. It expires in 834 day(s) on January 15, 2027. Parties traded 50 contract(s) at a $15.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $36.4K, with a price of $730.0 per contract. There were 251 open contracts at this strike prior to today, and today 50 contract(s) were bought and sold. 
• Regarding NU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), we observe a call option sweep with bullish sentiment. It expires in 470 day(s) on January 16, 2026. Parties traded 39 contract(s) at a $7.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $680.0 per contract. There were 4232 open contracts at this strike prior to today, and today 49 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a call option trade with neutral sentiment. It expires in 1 day(s) on October 4, 2024. Parties traded 22 contract(s) at a $482.50 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $1213.0 per contract. There were 10 open contracts at this strike prior to today, and today 22 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

FUTU

HOOD

TIGR

10 Financials Stocks Whale Activity In Today's Session

B of A Securities analyst Joshua Shanker maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $235 to $248.

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on Marsh & McLennan, Raises Price Target to $248

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.marshmclennan.com&amp;esheet=54128665&amp;newsitemid=20240930309858&amp;lan=en-US&amp;anchor=Marsh+McLennan&amp;index=1&amp;md5=63108aa7cc979825dd4a7df9434061de">Marsh McLennan</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), a global leader in risk, strategy and people, today announced that it has reached an agreement through its Marsh McLennan Agency business to acquire McGriff Insurance Services, LLC, an affiliate of TIH. McGriff is a leading provider of insurance broking and risk management services in the United States, with $1.3 billion of revenue for the trailing twelve months ended June 30, 2024. The transaction will enhance Marsh McLennan Agency's capabilities across commercial property and casualty, employee benefits, management liability and personal lines.
Under the terms of the transaction, Marsh McLennan will pay $7.75 billion in cash consideration, funded by a combination of cash and proceeds from debt financing. In conjunction with the transaction, Marsh McLennan will assume a deferred tax asset valued at approximately $500 million. The transaction is targeted to close by year-end, subject to regulatory clearance and other standard closing conditions.

Marsh McLennan To Snap McGriff Insurance Services For $7.75B

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 3.51% on an annualized basis producing an average annual return of 17.79%. Currently, Marsh &amp; McLennan has a market capitalization of $109.93 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 5 years ago, it would be worth $2,227.99 today based on a price of $223.55 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727274619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,200 Today

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/13/24</td>
<td>$19.50</td>
<td>$43.5K</td>
<td>747</td>
<td>6.5K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$7.50</td>
<td>$65.0K</td>
<td>5.5K</td>
<td>6.0K</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$75.00</td>
<td>$153.7K</td>
<td>9.1K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MMC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$210.00</td>
<td>$270.0K</td>
<td>286</td>
<td>1.0K</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/13/24</td>
<td>$45.00</td>
<td>$41.1K</td>
<td>208</td>
<td>967</td>
</tr>
<tr>
<td>KKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$120.00</td>
<td>$104.4K</td>
<td>49</td>
<td>500</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$65.00</td>
<td>$67.5K</td>
<td>227</td>
<td>224</td>
</tr>
<tr>
<td>COIN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$180.00</td>
<td>$533.0K</td>
<td>2.1K</td>
<td>217</td>
</tr>
<tr>
<td>CFG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$42.50</td>
<td>$31.2K</td>
<td>818</td>
<td>200</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$40.00</td>
<td>$25.2K</td>
<td>1.4K</td>
<td>176</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option sweep that happens to be bullish, expiring in 8 day(s) on September 13, 2024. This event was a transfer of 926 contract(s) at a $19.50 strike. This particular call needed to be split into 91 different trades to become filled. The total cost received by the writing party (or parties) was $43.5K, with a price of $47.0 per contract. There were 747 open contracts at this strike prior to today, and today 6525 contract(s) were bought and sold. 
• Regarding SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we observe a put option sweep with bullish sentiment. It expires in 15 day(s) on September 20, 2024. Parties traded 1627 contract(s) at a $7.50 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $65.0K, with a price of $40.0 per contract. There were 5571 open contracts at this strike prior to today, and today 6090 contract(s) were bought and sold. 
• For PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we notice a call option trade that happens to be bearish, expiring in 43 day(s) on October 18, 2024. This event was a transfer of 750 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $153.7K, with a price of $205.0 per contract. There were 9197 open contracts at this strike prior to today, and today 1284 contract(s) were bought and sold. 
• For MMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), we notice a put option trade that happens to be bullish, expiring in 106 day(s) on December 20, 2024. This event was a transfer of 1000 contract(s) at a $210.00 strike. The total cost received by the writing party (or parties) was $270.0K, with a price of $270.0 per contract. There were 286 open contracts at this strike prior to today, and today 1003 contract(s) were bought and sold. 
• For USB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>), we notice a put option sweep that happens to be bearish, expiring in 8 day(s) on September 13, 2024. This event was a transfer of 698 contract(s) at a $45.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $41.1K, with a price of $59.0 per contract. There were 208 open contracts at this strike prior to today, and today 967 contract(s) were bought and sold. 
• For KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), we notice a call option sweep that happens to be bullish, expiring in 197 day(s) on March 21, 2025. This event was a transfer of 90 contract(s) at a $120.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $104.4K, with a price of $1160.0 per contract. There were 49 open contracts at this strike prior to today, and today 500 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a call option trade that happens to be bullish, expiring in 498 day(s) on January 16, 2026. This event was a transfer of 90 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $67.5K, with a price of $750.0 per contract. There were 227 open contracts at this strike prior to today, and today 224 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on October 18, 2024. This event was a transfer of 200 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $533.0K, with a price of $2665.0 per contract. There were 2182 open contracts at this strike prior to today, and today 217 contract(s) were bought and sold. 
• Regarding CFG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>), we observe a put option sweep with bearish sentiment. It expires in 43 day(s) on October 18, 2024. Parties traded 136 contract(s) at a $42.50 strike. This particular put needed to be split into 33 different trades to become filled. The total cost received by the writing party (or parties) was $31.2K, with a price of $230.0 per contract. There were 818 open contracts at this strike prior to today, and today 200 contract(s) were bought and sold. 
• For UPST (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>), we notice a call option trade that happens to be bearish, expiring in 106 day(s) on December 20, 2024. This event was a transfer of 50 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $25.2K, with a price of $504.0 per contract. There were 1447 open contracts at this strike prior to today, and today 176 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFRM

COIN

PYPL

SOFI

UPST

Barclays analyst Alex Scott initiates coverage on Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight rating and announces Price Target of $236.

Initiation

Barclays Initiates Coverage On Marsh & McLennan with Equal-Weight Rating, Announces Price Target of $236

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 5.45% on an annualized basis producing an average annual return of 18.55%. Currently, Marsh &amp; McLennan has a market capitalization of $112.63 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 5 years ago, it would be worth $229.97 today based on a price of $229.03 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725471011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 4.26% on an annualized basis producing an average annual return of 16.47%. Currently, Marsh &amp; McLennan has a market capitalization of $111.29 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 15 years ago, it would be worth $9,840.00 today based on a price of $226.32 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724790613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,800 Today

Shares of&nbsp;Employers Holdings, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eig#NYSE">EIG</a>) have declined 5.8% since it reported second-quarter 2024 results on Jul 31, after the closing bell. The better-than-expected earnings were aided by growth in premiums written, policies in force and higher yields on fixed maturity securities. However, the positives were partially offset by increased overall expenses.
EIG reported second-quarter adjusted earnings per share of $1.10, which surpassed the Zacks Consensus Estimate by 1.9%. However, the bottom line fell 6% year over year.
Total revenues grew 0.8% year over year to $217 million. But the top line missed the consensus mark by 3%.
<div class="chart_embed">
<h3>Employers Holdings Inc Price, Consensus and EPS Surprise</h3>
<img alt="Employers Holdings Inc Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/a7/1723643799.png" style="border-style:solid; border-width:1px; height:310px; width:600px" title="" />
Employers Holdings Inc price-consensus-eps-surprise-chart | Employers Holdings Inc Quote
</div>
<h3>Q2 Key Updates</h3>
Gross premiums written of $207.9 million advanced 5% year over year in the quarter under review on the back of new business growth and higher renewal rates, partly offset by decreased final audit premiums. Net premiums written of $206.1 million increased 5% year over year.
Net premiums earned by Employers Holdings amounted to $187.8 million, which improved 6% year over year but lagged the Zacks Consensus Estimate by 4.6%.
Net investment income climbed 0.4% year over year to $26.9 million in the second quarter due to increased yields on fixed-maturity securities. However, the decline in invested balances of fixed-maturity securities partially offset the growth. As such, the metric missed the consensus mark by only 0.1%.
Total expenses of $177 million inched up 3.3% year over year. Losses and loss adjustment expenses recorded a 20% year-over-year rise due to growth in earned premiums and increased current accident year loss and loss adjustment expense ratio. Commission expenses grew 14% year over year.
EIG reported a pre-tax income of $40 million in the quarter under review, which fell 8.7% year over year.
Policies in force were at a record level of 128,522, which increased 3% year over year.
The combined ratio increased 380 basis points (bps) year over year to 94.2% but came lower than the Zacks Consensus Estimate of 95.5%. Underwriting and general and administrative expense ratio improved 400 bps year over year to 22%.
<h3>Financial Update (as of Jun 30, 2024)</h3>
Employers Holdings exited the second quarter with investments, cash and cash equivalents of $2.47 billion, which fell from the 2023-end level of $2.5 billion.
Total assets of $3.6 billion remained flat from 2023 end.
Total stockholders&#39; equity improved from the 2023-end level of $1.01 billion to $1.02 billion.
Adjusted book value per share was $48.89, which rose from $45.41 a year ago.
<h3>Capital Deployment Update</h3>
Employers Holdings bought back shares worth $19.2 million in the second quarter. It had a leftover capacity of $44.4 million under its repurchase authorization as of Jul 31, 2024.
Management announced a quarterly&nbsp;dividend of 30 cents for the third quarter, which will be paid on Aug 28, 2024, to shareholders as of Aug 14.
<h3>Zacks Rank &amp; Key Picks</h3>
EIG currently carries a Zacks Rank #3 (Hold).
Investors interested in the broader&nbsp;Finance space may look at some better-ranked players like Aflac Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afl#NYSE">AFL</a>), Brown &amp; Brown, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Marsh &amp; McLennan Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>), each carrying a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for Aflac&#39;s current-year earnings is pegged at $6.73 per share, which indicates 8% year-over-year growth. It witnessed seven upward estimate revisions in the past 30 days against no downward movements. AFL beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 8.2%.
The Zacks Consensus Estimate for Brown &amp; Brown&#39;s 2024 earnings indicates 30.6% year-over-year growth. During the past month, BRO has witnessed five upward estimate revisions against none in the opposite direction. It beat earnings estimates in each of the past four quarters, with an average surprise of 9.8%.
The Zacks Consensus Estimate for Marsh &amp; McLennan&#39;s current-year earnings suggests a 9.4% year-over-year jump. During the past month, MMC has witnessed seven upward estimate revisions against none in the opposite direction. The consensus mark for current-year revenues indicates 6.7% growth from a year ago.
<a href="https://www.zacks.com/stock/news/2322186/employers-holdings-eig-drops-5-8-despite-q2-earnings-beat?cid=CS-BENZ-FT-analyst_blog|earnings_article-2322186">To read this article on Zacks.com click here.</a>

Earnings Beats

Large Cap

Dividends

Small Cap

Management

Employers Holdings Drops 5.8% Despite Q2 Earnings Beat

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 4.25% on an annualized basis producing an average annual return of 16.18%. Currently, Marsh &amp; McLennan has a market capitalization of $107.89 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 15 years ago, it would be worth $9,372.50 today based on a price of $219.39 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723226427_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,400 Today

AMERISAFE, Inc.&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio. An elevated operating expense level, resulting from an increase in loss and loss adjustment expenses incurred, underwriting and other operating costs and policyholder dividends, also contributed to the downside. Improved audit premiums partially offset the negatives.
AMSF reported second-quarter adjusted earnings per share of 58 cents, which missed the Zacks Consensus Estimate by 4.9%. Moreover, the bottom line dipped 20.5% year over year.
Operating revenues improved 3.4% year over year to $76 million. The top line beat the consensus mark by 2.4%.
<div class="chart_embed">
<h3>AMERISAFE, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="AMERISAFE, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/32/1722871229.png" style="height:265px; width:620px" title="" />
AMERISAFE, Inc. price-consensus-eps-surprise-chart | AMERISAFE, Inc. Quote
</div>
<h3>Q2 Performance</h3>
Net premiums earned of $68.6 million improved 4.6% year over year in the quarter under review and outpaced the Zacks Consensus Estimate of $66 million. The metric benefited from improved contributions from payroll audits and related premium adjustments as a result of persistent payroll strength.
Net investment income dipped 3.6% year over year to $7.4 million due to a reduced portfolio size. However, this was partially offset by improved reinvestment rates. The metric fell short of the consensus mark of $7.8 million. Fee and other losses were $75 million.
AMERISAFE reported a pre-tax underwriting profit of $6.5 million, which declined 31.2% year over year.
Total expenses escalated 10.7% year over year to $62.1 million in the second quarter.
Operating net income of $11.1 million decreased 20.2% year over year.
The net combined ratio deteriorated 510 basis points (bps) year over year to 90.5% and came higher than the consensus mark of 90%. The metric suffered due to a deteriorating net loss ratio.
<h3>Financial Update (as of Jun 30, 2024)</h3>
AMERISAFE exited the second quarter with cash and cash equivalents of $30.6 million, which declined 20.9% from the 2023-end level.
Total assets of $1.2 billion increased 0.4% from the figure in 2023-end.
Shareholders&#39; equity of $301 million grew 2.9% from the 2023-end level.
Book value per share was $15.78 as of Jun 30, 2024, which improved 3.3% from the 2023-end figure.
Return on average equity deteriorated 400 bps year over year to 14.6% in the quarter under review.
<h3>Dividend Update</h3>
Management announced a quarterly cash dividend of 37 cents per share, which will be paid out on Sep 20, 2024, to its shareholders of record as of Sep 6.
<h3>Zacks Rank</h3>
AMERISAFE currently carries a Zacks Rank #4 (Sell).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2316354/amerisafe-amsf-stock-down-5-3-since-q2-earnings-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2316354">To read this article on Zacks.com click here.</a>

Earnings Misses

AMSF

KNSL

AMERISAFE Stock Down 5.3% Since Q2 Earnings Miss

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here's a look at the Benzinga Stock Whisper Index for the week of August 2:
Read Also: <a href="https://www.benzinga.com/top-stories/24/08/40119459/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-july-2024-where-do-tesla-nvidia-apple-crow">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?</a>
Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): The healthcare company saw strong interest from readers during the week, which may coincide with recent <a href="https://www.gilead.com/news-and-press/press-room/press-releases/2024/7/gilead-presents-research-data-across-its-broad-and-innovative-hiv-treatment-portfolio-and-pipeline">updates </a>on its HIV treatment pipeline. The company shared new five-year clinical data for Biktarvy at the 25th International AIDS Conference. 
Gilead also highlighted safety results of Lenacapavir for HIV Prevention. Lenacapavir could be the first and only twice-yearly PrEP treatment. Gilead is set to report second-quarter financial results on Aug. 8, which could see the stock getting strong attention in the next trading week. Raymond James <a href="https://www.benzinga.com/quote/GILD/analyst-ratings">upgraded shares </a>from Market Perform to Outperform in early July.
Gilead shares are down around 0.9% over the last week, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="510" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96.png" alt="" class="wp-image-473465" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96-768x391.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
QuantumScape (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>): The battery technology company saw shares decline after reporting second-quarter results. The stock saw a large increase in search interest from Benzinga readers. 
QuantumScape missed earnings per share estimates. An <a href="https://www.benzinga.com/news/earnings/24/07/39944935/quantumscape-stock-falls-on-q2-results-heres-why">update on liquidity</a> could be something for investors to watch as the company works to develop solid-state batteries. QuantumScape ended the quarter with $938 million in liquidity and said a recent licensing deal with PowerCo extends its cash runway into 2028, which could alleviate future financing concerns. 
QuantumScape was on the Stock Whisper Index<a href="https://www.benzinga.com/general/biotech/24/07/39752236/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet"> back in July</a> as shares surged from the announced agreement with PowerCo, which is a unit of Volkswagen Group. As part of the agreement, QuantumScape will receive royalty payments. The deal is non-exclusive, which could open QuantumScape up to make additional licensing deals in the future.
QuantumScape shares were down 17% on the week, as seen in the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97.png" alt="" class="wp-image-473473" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97-300x146.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97-768x374.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Marsh &amp; McLennan Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>): The professional services company saw increased interest from investors. The company announced its completion of the acquisition of The Horton Group, which expands its operations and increases its presence in Indiana, Illinois, Michigan, Minnesota, Wisconsin and Florida. 
The company beat earnings per share estimates from analysts in the second quarter, while missing revenue estimates. The closing of the acquisition will be something to watch in future quarters, along with updates on how its AI-powered solutions are performing with clients.
The stock was up 4.4% over the last week, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart </a>below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="498" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98.png" alt="" class="wp-image-473477" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>): The semiconductor stock has consistently qualified for inclusion in the Stock Whisper Index for several weeks, reflecting its significant increase in investor interest. However, semiconductor stocks experienced a decline during the recent trading week. While many of the stocks in the sector are up year-to-date, ON shares are down 17% year-to-date. The company <a href="https://www.benzinga.com/news/earnings/24/07/40010835/on-semiconductor-q2-earnings-revenue-and-eps-beat-ceo-highlights-automotive-gains-strong-q3-outlook">beat analysts' estimates </a>for earnings per share and revenue in the recently reported second quarter.
Several analysts<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40043794/on-semiconductor-manages-profitability-against-odds-5-analysts-raise-forecasts-as-i"> raised their price targets</a> on the stock after the earnings report with datacenter strength, product development, design wins and cost management among the positives mentioned.
The company highlighted a recent supply agreement with Volkswagen Group in the automotive sector during second-quarter results. Automotive continues to be an area of growth for many semiconductor companies and could be an area to watch when it comes to ON Semiconductor.
The stock was down 10.8% over the last week, as shown on the<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"> Benzinga Pro chart </a>below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99.png" alt="" class="wp-image-473479" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99-768x385.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>): The retail stock is among the biggest trending stocks over the last week, based on Benzinga data. Costco recently announced a<a href="https://www.benzinga.com/news/24/07/39718791/costco-stock-is-rising-along-with-its-membership-fees-whats-going-on"> long-awaited membership fee hike.</a> The company will raise the cost of its annual membership fee by $5 or $10 depending on the plan, impacting around 52 million members. 
Analysts said the membership fee increase <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39736078/costco-hikes-membership-fees-at-long-last-analysts-caution-of-sell-the-news-event-p">could add more than</a> $370 million in revenues over the next two years. While some analysts were bullish on the increase, others pointed to it being a "sell the news" event and potentially already priced into the stock. One analyst also pointed to Costco stock underperforming after the last three membership fee hikes.  
With Costco shares down 4% over the last month and nearly flat over the last week, as seen on the chart below, investors could be looking to get back into Costco with the future revenue increase coming.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100.png" alt="" class="wp-image-473482" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100-768x391.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/07/39648895/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 5</a></li>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39752236/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 12</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/07/39866122/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 19</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/07/39986280/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">July 26</a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40011559/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields</a></li>
</ul>
Image: Benzinga

Exclusives

COST

GILD

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

CNO Financial Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>) reported second-quarter 2024 adjusted earnings per share of $1.05, which beat the Zacks Consensus Estimate by 45.8%. Moreover, the bottom line rose 94.4% year over year.
Total revenues increased 4.2% year over year to $1.07 billion in the second quarter. The top line beat the consensus mark by 16.4%.
The strong second-quarter results benefited from improved insurance product margin, premiums, and general account assets.&nbsp;However, the decline of the policyholder and other special-purpose portfolios partially offset the results.
<div class="chart_embed">
<h3>CNO Financial Group, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="CNO Financial Group, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/84/1722441570.png" style="height:265px; width:600px" title="" />
CNO Financial Group, Inc. price-consensus-eps-surprise-chart | CNO Financial Group, Inc. Quote
</div>
<h3>Second-Quarter Performance</h3>
Total insurance policy income of $641.5 million improved 2.1% year over year and beat the Zacks Consensus Estimate by 1.2% due to a rise in annuity, health and life insurance policy incomes.
CNO&#39;s net investment income increased 2.4% year over year to $409.1 million in the second quarter. General account assets grew 8.3% year over year to $351.7 million and beat the consensus mark by 14.1%. However, the policyholder and other special-purpose portfolios declined 37.3% year over year to $57.4 million.
Annuity collected premiums of $439.1 million increased 9.3% year over year. New annualized premiums for health and life products improved 4.3% year over year to $102.9 million. Annuity, Health and Life products accounted for 27.7%, 49.4% and 22.9%, respectively, of CNO&#39;s insurance margin.
Total benefits and expenses were $915.6 million, which declined 1.2% year over year. The decline in the metric was due to liability for future policy benefits remeasurement gain and a decline in other operating costs and expenses.
<h3>Financial Update (as of Jun 30, 2024)</h3>
CNO Financial exited the second quarter with unrestricted cash and cash equivalents of $878.8 million, which increased from the 2023-end level of $774.5 million. Total assets of $36.3 billion increased from $35.1 billion at 2023-end.
The debt-to-capital ratio was 43% at the end of the second quarter. It has no outstanding debt maturities till 2025.
Total shareholders&#39; equity jumped to $2.4 billion from $2.2 billion as of Dec 31, 2023.
Book value per diluted share increased to $36 in the second quarter from $33.94 at 2023-end. Adjusted operating return on equity came in at 11.2%, which improved from 8% a year ago.
<h3>Share Repurchase and Dividend Update</h3>
CNO Financial rewarded its shareholders with $60 million in the form of share buybacks and dividends of $17.2 million.
As of Jun 30, 2024, the company had remaining repurchase funds of $421.8 million.
<h3>2024 Guidance</h3>
<h3>New Update</h3>
CNO Financial now expects 2024 EPS in the range of $3.30-$3.50, indicating an increase of 10% from the 2023 figure of $3.09. The company expects the expense ratio to be in the range of 19%-19.2% for 2024, improving from the 2023 level of 19.4%. It expects $200-$250 million excess cash flow to the holding company.
<h3>Previous View</h3>
The company continues to anticipate the effective tax rate for 2024 to be around 23%. It is also aiming at a leverage of 25%-28% for this year.
<h3>Zacks Rank</h3>
CNO Financial currently carries a Zacks Rank #3 (Hold).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2313385/cno-financial-cno-q2-earnings-beat-estimates-24-eps-view-up?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313385">To read this article on Zacks.com click here.</a>

Guidance

CNO Financial Q2 Earnings Beat Estimates, '24 EPS View Up

Willis Towers Watson Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtw#NASDAQ">WTW</a>) delivered second-quarter 2024 adjusted earnings of $2.55 per share, which beat the Zacks Consensus Estimate by 11.8%.&nbsp; The bottom line increased 24% year over year.
The insurer&#39;s second-quarter results benefited from the strong revenue contribution from the Health, Wealth &amp; Career and Risk &amp; Broking segments, as well as expanded margin, partly offset by elevated expenses.
<div class="chart_embed">
Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise
<img alt="Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/10/1721911828.png" style="height:265px; width:591px" title="" />
Willis Towers Watson Public Limited Company price-consensus-eps-surprise-chart | Willis Towers Watson Public Limited Company Quote
</div>
<h3>Operational Update</h3>
Willis Towers posted adjusted consolidated revenues of $2.26 billion, up 5% year over year on a reported basis. Revenues increased 6% on both organic basis and constant currency basis. The top line beat the Zacks Consensus Estimate by 0.04%.
The total costs of providing services increased 1.7% year over year to $2 billion due to higher salaries and benefits, transaction and transformation and other operating expenses. The metric matched our estimate.
Adjusted operating income was $385 million, which increased 22% year over year. The figure was higher than our estimate of $343 million. Margin expanded 240 basis points (bps) to 17%.
Adjusted EBITDA was $466 million, up 13% year over year. The figure was higher than our estimate of $437.4 million. Adjusted EBITDA margin expanded 160 bps to 20.6%.
<h3>Quarterly Segment Update</h3>
Health, Wealth &amp; Career: Total revenues of $1.2 billion increased 4% year over year (4% increase on a constant currency and 5% increase on organic basis). The figure matched the Zacks Consensus Estimate as well as our estimate.
Organic revenue growth in Health was driven by increased project work in North America and strong client retention, new local appointments and the continued expansion of Global Benefits Management client portfolio in International and Europe.
Wealth businesses generated organic revenue growth from higher levels of Retirement work in North America and Europe and an increase in Investments business due to capital market improvements and growth from LifeSight solution.
Career had organic revenue growth from increased project work and product revenues in Employee Experience and Work &amp; Rewards.
The operating margin was 21.9%, which expanded 360 bps from the prior-year quarter, primarily from operating leverage and Transformation savings.
Risk &amp; Broking: Total revenues of $979 million increased 9% year over year (10% increase in constant currency as well as on an organic basis) and beat our estimate of $954 million and the Zacks Consensus Estimate $958 million.
Corporate Risk &amp; Broking had organic revenue growth, primarily driven by higher levels of new business activity, strong client retention and renewal increases across all geographies. Insurance Consulting and Technology had flat organic revenue growth in the reported quarter, primarily due to tempered demand for discretionary services.
The operating margin increased 450 bps from the prior-year quarter to 20.6%, primarily due to operating leverage from strong revenue growth in CRB, Transformation savings and interest income.
<h3>Financial Update</h3>
As of Jun 30, 2024, cash and cash equivalents was $1.2 billion, down 22% year over year.
Long-term debt increased 16.2% to $5.3 billion at quarter-end from the end of 2023.
Shareholders&#39; equity decreased 1.9% from the level on Dec 31, 2023, to $9.3 billion as of Jun 30, 2024.
Cash flow from operations was $431 million in the first half of 2024, which inched up 0.2% from the prior-year period.
Free cash flow for the first half of 2024 increased 3.1% to $361 million.
<h3>2024 Outlook</h3>
Willis Towers expects to deliver revenues of more than $9.9 billion.
The insurer projects to deliver an adjusted operating margin in the band of 23-23.5%.&nbsp;
Willis Towers expects to deliver adjusted diluted earnings per share in the range of $16-$17.
WTW expects Transformation Program annual cost savings of $450 million.
The insurer expects approximately $88 million in non-cash pension income. It expects a foreign currency headwind on adjusted earnings per share of approximately 10 cents.
<h3>Zacks Rank</h3>
Willis Towers currently carries a Zacks Rank #3 (Hold).
<h3>Performance of Some Other Insurers</h3>
Brown &amp; Brown, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) second-quarter 2024 adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the Zacks Consensus Estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion. Our estimate for commission and fees growth was 7.2%.
Organic revenues improved 10% to $1 billion in the quarter under review. Investment income more than doubled year over year to $22 million. The Zacks Consensus Estimate for the metric was pegged at $18.6 million and our estimate was $23.2 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%. Our estimate for adjusted EBITDAC was $411.4 million.
Marsh &amp; McLennan Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>) reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year. Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.
The top line, however, fell short of the consensus mark by 1%. Total operating expenses of $4.58 billion increased 3.6% year over year but were lower than our estimate of $4.62 billion. MMC&#39;s adjusted operating income was $1.72 billion in the second quarter, which grew 11% year over year and beat our estimate of $1.68 billion. Adjusted operating margin improved 130 bps year over year to 29%.
Selective Insurance Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sigi#NASDAQ">SIGI</a>) reported second-quarter 2024 operating loss of $1.10 per share against the Zacks Consensus Estimate for earnings of $1.56. The company had reported an operating income of 99 cents per share in the prior-year quarter. Total revenues of $1.2 billion increased 15% from the year-ago quarter&#39;s figure, primarily due to higher premiums earned, net investment income and net premiums written. The top line missed the Zacks Consensus Estimate by 1.3%.
On a year-over-year basis, net premium written increased 13% to $1.22 billion. The figure matched our estimate. After-tax net investment income increased 11% year over year to $86 million. After-tax net underwriting loss was $137.2 million against the year-ago underwriting income of $1.2 million. Pre-tax catastrophe losses of $91 million were narrower than a loss of $100 million reported in the year-ago quarter. The combined ratio deteriorated 1,590 bps on a year-over-year basis to 116.1.
<a href="https://www.zacks.com/stock/news/2309154/willis-towers-wtw-q2-earnings-beat-estimates-improve-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2309154">To read this article on Zacks.com click here.</a>

SIGI

Willis Towers Q2 Earnings Beat Estimates, Improve Y/Y

Offerings

Marsh & McLennan Files For Mixed Shelf, Size Not Disclosed

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 20 years by 3.75% on an annualized basis producing an average annual return of 12.14%. Currently, Marsh &amp; McLennan has a market capitalization of $107.87 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 20 years ago, it would be worth $9,734.19 today based on a price of $219.36 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721671219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 20 Years

RBC Capital analyst Mark Dwelle maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Sector Perform and raises the price target from $228 to $232.

RBC Capital Maintains Sector Perform on Marsh & McLennan, Raises Price Target to $232

Roth MKM analyst Harry Fong maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $200 to $220.

Roth MKM Maintains Neutral on Marsh & McLennan, Raises Price Target to $220

It&#8217;s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market&#8217;s fear gauge, spiked over 10%, reaching levels last seen in late April.
Both the S&amp;P 500 and the Nasdaq 100 indices declined by 0.6%, while the Dow Jones Industrial Average fell 0.7%, potentially ending a streak of <a href="https://www.benzinga.com/top-stories/24/07/39827103/dow-jones-extends-all-time-highs-blue-chips-post-strongest-6-day-gain-versus-tech-stocks-in-22-years">six consecutive positive sessions.</a>
Small-cap stocks also succumbed to the broader negative sentiment, with the Russell 2000 index dropping 0.7%.
Chicago Fed President Austan Goolsbee, a known &#8220;dove&#8221; on the board, expressed optimism about progress on inflation and the U.S. economy&#8217;s resilience in avoiding a recession. He did not commit to a potential <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39843875/feds-goolsbee-confident-with-inflations-golden-path-but-wont-tie-committee-hands-">rate cut in September.</a>
Following Wednesday&#8217;s sell-off triggered by concerns over increased U.S. chip export restrictions to China, semiconductor stocks remained broadly weaker, with the iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) down by 0.6%. Despite this, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) defied the trend, rising 1.8%.
Significant volatility erupted in the health care sector, particularly within the weight loss drug industry. The market duopoly of Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) and Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) face heightened competitive threats from Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and Roche Holding Ltd (OTCPK: RHHBY), both of which recently announced developments to enter this lucrative market.
Shares of Eli Lilly plunged 5.6%, marking their worst session since mid-March 2021, while Novo Nordisk shares dropped 5%, their worst performance since August 2022.
On the economic data front, jobless claims rose more than expected last week and continuing claims reached their highest level since November 2021, indicating a cooling trend <a href="https://www.benzinga.com/etfs/sector-etfs/24/07/39837570/unemployment-claims-rise-more-than-expected-boosting-hopes-for-rate-cuts-as-cracks-in-labor-mark">in the labor market.</a>
The U.S. dollar acted as a safe haven, rising 0.3%, while Treasury yields inched higher across the curve. The European Central Bank kept interest rates unchanged, as expected, keeping the <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39838605/european-central-bank-holds-interest-rates-unchanged-keeps-markets-guessing-on-se">door open for September.</a>
In commodities, growth-sensitive copper tumbled over 3%, hitting its lowest level since mid-April. Silver eased by 0.9% and gold remained flat. Oil prices slipped 0.3%, while natural gas surged over 4%, nearly recouping Wednesday&#8217;s sharp losses following a weaker-than-expected buildup in inventories last week.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged 0.4% lower, eyeing a second consecutive negative close.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,687.70</td>
<td>-0.6%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,556.41</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,929.46</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,220.63</td>
<td>-0.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">Benzinga pro</a> data: 
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was 0.6% lower to $553.74.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;fell by 0.7% to $409.10.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(ARCA:&nbsp;<a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a>QQQ) fell 0.5% to $479.14.</li>
<li>Sector-wise, the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)&nbsp;outperformed, up by 1%, while the&nbsp;Health Care Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Market Movers</h3>
<ul>
<li>Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) fell 0.9% despite reporting stronger-than-expected results last quarter.</li>
<li>Other stocks reacting to corporate earnings were Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), down 3.5%, Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>), down 1%, SL Green Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) down 2.5%, Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), up 3.8%, Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>), down 13%, Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), up 2.6%, Marsh &amp; McLennan Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), down 1%, Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>), down over 5%, Cintas Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>), up over 6%, D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), up 13%, Virtu Financial Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>), up 18% and Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), down 4.4%.</li>
<li>Companies reporting after the close include Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/government/24/07/39841598/project-2025-wants-to-radically-change-us-tax-policy-would-you-pay-more-or-less-in-taxes">Project 2025 Wants To Radically Change US Tax Policy: Would You Pay More Or Less In Taxes?</a></li>
</ul>
Photo via Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Health Care

Commodities

Treasuries

Econ #s

Economics

Federal Reserve

ETFs

$BTC

CTAS

SPDR Dow Jones Industrial Average ETF Trust

ISRG

NVDA

RHHBY

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

VIRT

VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?

Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) <a href="https://www.benzinga.com/markets/asia/24/07/39832197/apple-nvidia-supplier-tsmc-reports-strong-q2-results-amid-booming-demand-for-ai-chips-guides-q3-abov">strong quarterly report </a>lifting sentiment toward tech stocks. The major U.S. index futures were mixed ahead of the trading session.
A few Fed speeches scheduled for the day, and key economic data, including jobless claims, the results of a regional manufacturing survey, and leading economic index may influence trading direction. Traders may also pay attention to the European Central Bank&#8217;s rate decision and its monetary policy outlook.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.40%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.15%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.13%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.03%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.18% to $557.94 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) added 0.41% to $483.74, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
Geopolitical concerns and apprehensions around the health of the tech reporting season weighed down on the market on Wednesday. The Nasdaq Composite and the S&amp;P 500 Index languished deep in the red throughout the session and ended notably lower, snapping a three-session winning streak. The former had its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39831761/as-trump-biden-tough-geopolitical-talk-razes-tech-stocks-munster-warns-of-ai-progre">worst one-day performance</a> since December 2022 and settled below the psychological 18,000 barrier for the first time since July 1.
Among S&amp;P 500 sectors, IT stocks fell the most, while communication services and consumer discretionary stocks also came under significant selling pressure. On the other hand, strength in healthcare, financial, energy, and consumer staple stocks mitigated some of the weaknesses.
The 30-stock Dow Industrials Average bucked the downtrend and rose for the sixth straight session, with Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) leading the charge following the pharma giant&#8217;s earnings release. Small-caps, however, retreated from a 2-1/2 year high.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.77%</td>
<td>17,996.92</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>-1.39%</td>
<td>5,588.27</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>-0.59%</td>
<td>41,198.08</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.06%</td>
<td>2,239.67</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Morgan Stanley Chief U.S. Economist Ellen Zentner said despite investor worries over economic data, the firm expects a soft landing for the U.S. economy. The firm expects three rate cuts, each 25 basis points, beginning in September. &#8220;However, increased labor market softness could prompt the Fed to bigger cuts to head off a recession,&#8221; she said.
Upcoming Economic Data:
<ul>
<li>The Labor Department is scheduled to release its jobless claims report at 8:30 a.m. EDT. Economists, on average, expect the number of individuals claiming unemployment benefits to come in at 229,000 in the week ended July 13, up from 222,000 in the previous week.</li>
<li>The Philadelphia Fed will release the results of its July regional manufacturing survey at 8:30 a.m. EDT. The consensus estimate calls for a reading of 2.9 for the headline diffusion index of business activity, up from 1.3 in June.</li>
<li>The Conference Board is due to release the leading economic index for June at 10 a.m. EDT. The index is expected to show a 0.3% drop in the index, not as worse as the 0.5% fall in May.</li>
<li>Chicago Fed President Austan Goolsbee will speak at 10 a.m. EDT, Dallas Fed President Lorie Logan at 1:45 p.m. EDT, San Francisco Fed President Mary Daly at 6:05 p.m. EDT, and Fed Governor Michelle Bowman at 7:45 P.m. EDT.</li>
<li>The Treasury will auction four- and eight-week bills at 11:30 a.m. EDT and 10-year TIPS auction at 1 p.m. EDT.</li>
</ul>
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus:
<ul>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) rose over 1% <a href="https://www.benzinga.com/premarket">in premarket trading</a> trading following the aluminum maker&#8217;s quarterly report. Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) fell over 2.50% and SL Green Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) gained over 3%.</li>
<li>Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) plunged over 10% on a slight revenue miss.</li>
<li>Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>), Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>), Marsh &amp; McLennan Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) and Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) are among the <a href="https://www.benzinga.com/calendars/earnings">notable companies reporting their quarterly results ahead of the market open.</a></li>
<li>Those reporting after the close include Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures were modestly lower, while gold futures rose. The 10-year Treasury yield climbed 4.2 points to 4.185%. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slipped below the $65,000 level.
The Asian markets had a mixed session, with Japan falling on weak trade data and Taiwanese and South Korean markets extending their slide. On the other hand, the Australian, Chinese, and Hong Kong markets ended in the green.
On the other hand, European stocks firmed up ahead of the rate decision. The European Central Bank is scheduled to announce its rate decision at 8:15 a.m. EDT, with economists anticipating that the bank will hold fire after reducing rates by 25 basis points at the last meeting.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39766859/netflix-goldman-sachs-j-j-asml-lead-q2-reports-this-week-as-analysts-see-earnings-growth-accelerati">Netflix, Goldman Sachs, J&amp;J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years</a></li>
</ul>
Image generated using Midjourney

Futures

Previews

Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens

Marsh & McLennan declares $0.815 dividend

AIG taps Marsh McLennan exec as its new CFO

Dividend Champion, Contender, And Challenger Highlights: Week Of September 29

Marsh McLennan to acquire McGriff Insurance for $7.5B

Marsh & McLennan: McGriff Acquisition Is A Good Deal

Analyst Elyse Greenspan from Wells Fargo maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) and decreased the price tar...

Assessing Marsh & McLennan's Acquisition of McGriff: Financial Impacts and Valuation Metrics

Bob Huang, an analyst from Morgan Stanley, maintained the Hold rating on Marsh & Mclennan Companies (MMC – Research Report). The associated price t...

Balancing Strategic Fit and Financial Caution: Hold Rating on Marsh & McLennan's McGriff Acquisition

BMO Capital analyst Michael Zaremski has maintained their neutral stance on MMC stock, giving a Hold rating yesterday. Michael Zaremski's rating is...

Marsh & McLennan Acquisition of McGriff: A Cautious Hold Amid Growth and Integration Risks

Analysts have been eager to weigh in on the Financial sector with new ratings on OneMain Holdings (OMF – Research Report) and Marsh & Mclennan Comp...

Analysts Offer Insights on Financial Companies: OneMain Holdings (OMF) and Marsh & Mclennan Companies (MMC)

Deutsche Bank analyst Cave Montazeri maintained a Buy rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of ...

Deutsche Bank  Sticks to Its Buy Rating for Marsh & Mclennan Companies (MMC)

BPOP

CADE

CFFI

CHCO

CHRW

CMCSA

CSCO

CTBI

CUBE

ERIE

FFIN

FISI

FMAO

FULT

FUNC

GAIN

HBNC

HLNE

HWBK

INDB

INGR

LRCX

MBIN

MORN

RGLD

SCVL

SFBS

SFNC

SPTN

SWBI

SYBT

THFF

UBSI

UMBF

UTMD

VICI

WASH

WSBC

Press Releases

Mercer Projects a Deficit of Over 100,000 Healthcare Workers in the US by 2028, Worsening Health Disparities and Impacting Patient Care

Marsh McLennan and Zurich Urge Public-Private Action to Bridge Cyber Protection Gap and Boost Resilience

Aon and Marsh McLennan Call on (Re)insurance Industry to Aid Ukraine's Resilience

Insurance

Aon and Marsh McLennan call on (re)insurance industry to aid Ukraine's resilience

Employers Expect Third Consecutive Year of Health Benefit Cost Increases Above 5% in 2025, According to Mercer

Marsh McLennan Declares Quarterly Cash Dividend

Marsh McLennan to host third quarter earnings investor call on October 17

Fintech

New Report by WeBank and Oliver Wyman Reveals Development and Innovation Trends of Global Digital Banks

Marsh McLennan to Acquire McGriff Insurance Services

Expansion of Paid Leave Mandates Creates Compliance Complexity for Employers, Says Mercer

Comments

Marsh & McLennan

뉴스

에 대한 최신 뉴스 Marsh & McLennan (NYSE:MMC) 주식

월요일, 5월 06, 2024

목요일, 4월 18, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌